€15M-backed tech targets tumour complexity
Paris-based One Biosciences, a precision oncology biotech company, has raised…
Paris-based One Biosciences, a precision oncology biotech company, has raised €15 million in Series A financing to accelerate the development of its AI-powered single-cell tumour profiling platform.